Editorial: in search of environmental risk factors of Crohn's disease and ulcerative colitis with mendelian randomisation-authors' reply.
Journal article
Chen J. et al, (2023), Alimentary pharmacology & therapeutics, 57, 1034 - 1035
Letter: disentangling the role of redox-active compounds in the development of inflammatory bowel diseases-moving towards causal associations. Authors' reply.
Journal article
Chen J. et al, (2023), Alimentary pharmacology & therapeutics, 57, 1048 - 1049
Defining gene-lifestyle interactions in inflammatory bowel disease: progress towards understanding disease pathogenesis.
Journal article
Zhao J. et al, (2023), Gut
Defining Interactions Between the Genome, Epigenome, and the Environment in Inflammatory Bowel Disease: Progress and Prospects.
Journal article
Noble AJ. et al, (2023), Gastroenterology
Intake of Ultra-processed Foods Is Associated with an Increased Risk of Crohn's Disease: A Cross-sectional and Prospective Analysis of 187 154 Participants in the UK Biobank.
Journal article
Chen J. et al, (2023), Journal of Crohn's & colitis, 17, 535 - 552
Early management of acute severe UC in the biologics era: development and international validation of a prognostic clinical index to predict steroid response.
Journal article
Adams A. et al, (2023), Gut, 72, 433 - 442
Considerations for peripheral blood transport and storage during large-scale multicentre metabolome research
Journal article
Alexander JL. et al, (2023), Gut
The Contribution of Genetic Risk and Lifestyle Factors in the Development of Adult-Onset Inflammatory Bowel Disease: A Prospective Cohort Study.
Journal article
Sun Y. et al, (2023), Am J Gastroenterol
Serum N-Glycomic Biomarkers Predict Treatment Escalation in Inflammatory Bowel Disease
Journal article
Shubhakar A. et al, (2023), Journal of Crohn's and Colitis
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial.
Journal article
Louis E. et al, (2023), Lancet Gastroenterol Hepatol
Antioxidants, minerals and vitamins in relation to Crohn's disease and ulcerative colitis: A Mendelian randomization study.
Journal article
Chen J. et al, (2023), Alimentary pharmacology & therapeutics
Bi-directional Mendelian randomization analysis provides evidence for the causal involvement of dysregulation of CXCL9, CCL11 and CASP8 in the pathogenesis of ulcerative colitis.
Journal article
Chen J. et al, (2022), Journal of Crohn's & colitis
Long-term temporal stability of peripheral blood DNA methylation profiles in patients with inflammatory bowel disease.
Journal article
Joustra V. et al, (2022), Cellular and molecular gastroenterology and hepatology
Decrease in uptake of SARS-CoV-2 vaccine in patients with inflammatory bowel disease on intravenous biological therapy.
Journal article
Selim R. et al, (2022), The lancet. Gastroenterology & hepatology
Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease
Journal article
Wellens J. et al, (2022), Gut, 71, 1919.2 - 1922
Analysis of systemic epigenetic alterations in inflammatory bowel disease: defining geographical, genetic, and immune-inflammatory influences on the circulating methylome.
Journal article
Kalla R. et al, (2022), Journal of Crohn's & colitis
Systematic Review and Meta-analysis of Peripheral Blood DNA methylation studies in Inflammatory Bowel Disease.
Journal article
Joustra V. et al, (2022), Journal of Crohn's & colitis
Author Correction: Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease
Journal article
Serra EG. et al, (2022), Nature Communications, 13
Observational data from the adalimumab post‐marketing PYRAMID registry of patients with Crohn's disease who became pregnant: A post hoc analysis
Journal article
Hart A. et al, (2022), United European Gastroenterology Journal, 10, 485 - 495
Mucosal metabolites fuel the growth and virulence of E. coli linked to Crohn’s disease
Journal article
Zhang S. et al, (2022), JCI Insight, 7